K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Kilitch Drugs (India) Ltd
NSE:KILITCH
Price:
324.3
INR
3.33%
Market Closed
Market Cap:
₹5.7B
Relative Value
The Relative Value of one KILITCH stock under the Base Case scenario is 383.33 INR. Compared to the current market price of 324.3 INR, Kilitch Drugs (India) Ltd is Undervalued by 15%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KILITCH
Relative Value
Base Case
383.33
INR
Undervaluation 15%
K
Multiples Across Competitors
KILITCH Competitors Multiples
Kilitch Drugs (India) Ltd Competitors
Kilitch Drugs (India) Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
5.7B INR | 2.7 | 21.4 | 19.2 | 21.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.3B USD | 15.2 | 47.9 | 32.3 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594.4B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
298.4B CHF | 4.9 | 31.7 | 13.3 | 15.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP | 5.5 | 31.8 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.3B CHF | 5.7 | 22.8 | 14 | 18.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
310B USD | 4.8 | 16.9 | 10.6 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.7 | 7.9 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.2B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.4B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
